NEW REPORT – Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era

New York and Tokyo (February 24, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key takeaways from their roundtable on healthy aging, innovation, and the silver economy. The October 2020 virtual roundtable convened experts from across the health, business, aging, and elder homecare sectors in a policy discussion to call on governments to recognize health spending as a critical investment for countries like Japan, who are leading the global megatrend of aging and placing innovation at the center of this investment. The roundtable was held by GCOA in collaboration with HGPI and sponsored by Pfizer Japan.

The roundtable was the first in a series on healthy ageing, innovation, and the silver economy led by GCOA and the Organization for Economic Development and Cooperation (OECD).

Five key takeaways emerged that shine a light on the importance of health innovation in Japan and in aging societies around the world:

  1. Japan needs innovation to ensure healthy longevity.
  2. To foster innovation, Japan must recognize spending on health innovation as an investment in healthy and active ageing.
  3. Cross-sector, cross-discipline, cross-geographical cooperation is essential for achieving health innovation.
  4. In Japan, investment in health innovation will require incentivizing those poised to lead the innovation.
  5. Global and Japanese-focused forums have set the stage for action to achieve new models for health innovation to fuel the silver economy.

Click here to read the report in English. Click here to read the report in Japanese.

The discussion was introduced by Michael W. Hodin, CEO of the GCOA, Hideki Makihara, Member of the Japanese Diet, and Yumiko Murakami, Head of the OECD Tokyo Centre.

Key comments during the roundtable included:

“Global collaboration and communication play a critical role in promoting health innovation and the silver economy,” said OECD’s Murakami. “With almost 30% of the population over 65 years old, Japan has the opportunity to demonstrate international leadership. Fostering health innovation is a key part of what we want to model for other aging societies.”

Mikiro Suga, Director, Health and Welfare Department, Japan External Trade Organization (JETRO) New York, said, “By pursing policy solutions that support health innovation and economic growth, Japan is laying the groundwork for a future with a strong economy, efficient healthcare spending, and a healthy, active, and robust population of older adults.”

Michael W. Hodin, CEO of GCOA, said the importance of incentivizing innovation, noting that “in sectors, like elder homecare, technology and medicines, increased innovation can result in greater functional ability for older adults and continued economic activity across the life course.”

Another mark of the value of supporting health innovation and investment was a virtual discussion convened by The Economist on November 25, 2020. Policymakers, clinicians, and experts gathered to discuss how to spur innovation in Japan’s life sciences sector while safeguarding the sustainability of its health system. Click here to read the summary in English. Click here to read the summary Japanese. The discussion was sponsored by Pfizer.

 

Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path to health, productivity and economic growth.

 

Health and Global Policy Institute (HGPI)

Health and Global Policy Institute (HGPI) is a Tokyo-based, independent, non-profit, and non-partisan health policy think tank established in 2004. Since its establishment, HGPI has been working to realize citizen-centric health policies by gathering together diverse stakeholders and developing policy recommendations. HGPI is committed to serving as a truly independent organization that can provide society with new ideas from a broad, long-term perspective in order to foster fair and healthy communities. HGPI looks forward to continuing to partner with people from all around the world as we continue our work for the development of effective health policy solutions for Japanese and global issues.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.